Get the Stockscreener App
1.24
1.59%
-0.02
After Hours:
1.40
0.16
+12.90%
Scienture Holdings Inc stock is traded at $1.24, with a volume of 3.96M.
It is down -1.59% in the last 24 hours and down -60.88% over the past month.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
See More
Previous Close:
$1.26
Open:
$1.27
24h Volume:
3.96M
Relative Volume:
4.66
Market Cap:
$11.15M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-48.55%
1M Performance:
-60.88%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.00
$1.35
1-Week Range:
$1.00
$2.15
52-Week Range:
$1.00
$9.55
Scienture Holdings Inc Stock (SCNX) Company Profile
Name
Scienture Holdings Inc
Sector
Industry
Phone
(800) 261 0281
Address
2420 BRUNELLO TRACE, LUTZ
Compare SCNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
1.24 | 11.15M | 0 | 0 | 0 | 0.00 |
|
WBA
Walgreens Boots Alliance Inc
|
11.26 | 9.74B | 147.66B | -8.64B | -363.00M | -10.01 |
|
HITI
High Tide Inc
|
2.19 | 177.17M | 376.07M | -22.41M | 18.73M | -0.298 |
|
WGRX
Wellgistics Health Inc
|
2.67 | 138.69M | 0 | 0 | 0 | 0.00 |
|
PETS
Petmed Express Inc
|
4.02 | 83.04M | 270.52M | -6.08M | 17.42M | -0.2944 |
Scienture Holdings Inc Stock (SCNX) Latest News
Scienture Holdings appoints new CFO, stockholders vote at annual meeting - Investing.com
Scienture Holdings Appoints New CFO Eric Sherb - TipRanks
Scienture Holdings Secures Exclusive Naloxone Agreement - TipRanks
United States shares higher at close of trade; Dow Jones Industrial Average up 0.52% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.52% - Investing.com
Best Stocks Under $5 Right Now - Benzinga
Nasdaq Down Over 400 Points; Kroger Posts Upbeat Earnings - Benzinga
What's Going On With Scienture Stock Thursday? - Benzinga India
Scienture Unit, Summit Biosciences Collaborate to Launch Naloxone Spray for Opioid Overdose Treatment in the US - Marketscreener.com
Dow Tumbles 1%; US Initial Jobless Claims Decline - Benzinga
Scienture (SCNX) Soars In Pre-Hour Trading After Strategic Business Development - Stocks Telegraph
SCNX Stock Price and Chart — NASDAQ:SCNX - TradingView
Scienture To Commercially Launch Rezenopy -March 06, 2025 at 08:03 am EST - Marketscreener.com
Scienture Holdings rises on launch of opioid overdose antidote Rezenopy - TradingView
SCIENTURE to commercially launch REZENOPY®, a life-saving - GlobeNewswire
Can This New High-Strength Naloxone Treatment Transform the $189M Opioid Crisis Market? - StockTitan
Scienture Holdings (FRA:4E4) Preferred Stock : €0.00 Mil (As of Sep. 2024) - GuruFocus.com
Biotech Stocks Facing FDA Decision In March 2025 - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga India
Scienture Holdings, Inc. Announces Dr. Narasimhan Mani’s - GlobeNewswire
Scienture Holdings, Inc. Announces Dr. Narasimhan Mani's Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics - The Manila Times
Scienture President to Keynote at Major SSX Pharma Conference, Spotlight Innovation Strategy - StockTitan
Scienture Holdings Board Restructures After Director Resignations - TipRanks
Scienture Holdings, Inc. Announces Director Resignations -January 17, 2025 at 04:05 pm EST - Marketscreener.com
Scienture Holdings Faces Nasdaq Compliance Challenge - TipRanks
Scienture Holdings, Inc. to Participate in The Microcap Conference 2025 - Nasdaq
Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025 - GlobeNewswire
Scienture Holdings to Present at Microcap Conference 2025: Strategic Growth Plans in Focus - StockTitan
Walgreens Boots Alliance (WBA) Stock Dips Amid Financial Challen - GuruFocus.com
Trxade Group, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com
Trxade Group, Inc. acquired Community Specialty Pharmacy, LLC from Nikul Panchal for $0.6 million. - Marketscreener.com
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041 - GlobeNewswire
Scienture Secures Crucial Patent Protection for Novel Losartan Oral Suspension Through 2041 - StockTitan
Scienture Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Scienture announces private placement of $3M of 10% secured convertible debentures - MSN
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement - The Manila Times
Scienture Holdings Secures Funding for Strategic Growth - TipRanks
Scienture Holdings Secures $62M in Strategic Financing, Including $12.2M Debenture Deal | SCNX Stock News - StockTitan
Walgreens Boots Alliance (WBA) Stock Surges Amid Market Activity - GuruFocus.com
Scienture Holdings: Q3 Earnings Snapshot - CTPost
White Mountains: Q3 Earnings Snapshot - AOL
TRxADE HEALTH, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 - Marketscreener.com
Scienture completes preferred stock conversion By Investing.com - Investing.com Australia
Scienture completes preferred stock conversion - Investing.com India
Scienture : Material Event Form 8 K - Marketscreener.com
Scienture Holdings Shares Insight with Investor Presentation - TipRanks
Gajan A. Mahendiran and Amudha Mahendiran acquired Westminster Pharmaceutical LLC from Trxade Group, Inc. for $1.6 million. - Marketscreener.com
Top Premarket Gainers - Marketscreener.com
Scienture Holdings Unveils New Identity Post-Merger - TipRanks
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
Scienture Holdings Inc Stock (SCNX) Financials Data
There is no financial data for Scienture Holdings Inc (SCNX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.42%
1.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):